Angiotensin AT 1 receptor-mediated vasopressin release and drinking are potentiated by an AT 2 receptor antagonist

By Hohle S.   Spitznagel H.   Rascher W.   Culman J.   Unger T.  

European Journal of Pharmacology, Vol. 275, Iss. 3, 1995-03 ,pp. : 277-282

Elsevier

Access to resources Recommend Favorite

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V_1a AND V₂ RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

By Yatsu T.   Kusayama T.   Tomura Y.   Arai Y.   Aoki M.   Tahara A.   Wada K-I.   Tsukada J.  

Pharmacological Research, Vol. 46, Iss. 5, 2002-11 ,pp. : 375-381

Academic Press

Access to resources Recommend Favorite

Potentiation of phencyclidine-induced dopamine release in the rat striatum by the blockade of dopamine D 2 receptor

By Yonezawa Y.   Kuroki T.   Tashiro N.   Hondo H.   Uchimura H.  

European Journal of Pharmacology, Vol. 285, Iss. 3, 1995-10 ,pp. : 305-308

Elsevier

Access to resources Recommend Favorite

Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3049-3053

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats

By Hefco V.   Yamada K.   Hefco A.   Hritcu L.   Tiron A.   Olariu A.   Nabeshima T.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 227-232

Elsevier

Access to resources Recommend Favorite